Preferred Label : Lynparza;
Obsolete resource : false;
Origin ID : M000600994;
UMLS CUI : C3872110;
Related record
- Semantic type(s)
https://www.has-sante.fr/jcms/p_3576306/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2025
false
false
false
France
evaluation of the transparency committee
olaparib
cancer
Imfinzi
endometrial neoplasms
durvalumab
Lynparza
endometrium
neoplasm, malignant
olaparib
association
olaparib
durvalumab
Endomet
---
https://www.has-sante.fr/jcms/p_3329237/fr/lynparza-olaparib
https://has-sante.fr/jcms/p_3329245/fr/decision-n-2022-0111/dc/sem-du-31-mars-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-lynparza
2022
false
false
false
France
evaluation of the transparency committee
Lynparza
olaparib
olaparib
olaparib
---
https://www.has-sante.fr/jcms/p_3224943
2020
France
evaluation of the transparency committee
Lynparza
olaparib
olaparib
pancreas
olaparib
---
